Found: 22
Select item for more details and to access through your institution.
Early depth of tumor shrinkage and treatment outcomes in non-small cell lung cancer treated using Nivolumab.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1257, doi. 10.1007/s10637-019-00770-y
- By:
- Publication type:
- Article
Correction to: Inhibitory effects of tea polyphenols by targeting cyclooxygenase-2 through regulation of nuclear factor kappa B, Akt and p53 in rat mammary tumors.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1247, doi. 10.1007/s10637-019-00825-0
- By:
- Publication type:
- Article
A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid component.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1239, doi. 10.1007/s10637-019-00817-0
- By:
- Publication type:
- Article
Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1266, doi. 10.1007/s10637-019-00843-y
- By:
- Publication type:
- Article
Discovery and anticancer evaluation of a formononetin derivative against gastric cancer SGC7901 cells.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1300, doi. 10.1007/s10637-019-00767-7
- By:
- Publication type:
- Article
Cellular uptake evaluation of pentagamaboronon-0 (PGB-0) for boron neutron capture therapy (BNCT) against breast cancer cells.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1292, doi. 10.1007/s10637-019-00765-9
- By:
- Publication type:
- Article
Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1274, doi. 10.1007/s10637-019-00760-0
- By:
- Publication type:
- Article
Novel palladium (II) complexes with tetradentate thiosemicarbazones. Synthesis, characterization, in vitro cytotoxicity and xanthine oxidase inhibition.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1187, doi. 10.1007/s10637-019-00751-1
- By:
- Publication type:
- Article
A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1166, doi. 10.1007/s10637-019-00750-2
- By:
- Publication type:
- Article
Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasion.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1177, doi. 10.1007/s10637-019-00748-w
- By:
- Publication type:
- Article
Population pharmacokinetic analysis of AR-67, a lactone stable camptothecin analogue, in cancer patients with solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1218, doi. 10.1007/s10637-019-00744-0
- By:
- Publication type:
- Article
Axitinib pharmacologic therapeutic monitoring reveals severe under-exposure despite titration in patients with metastatic renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1289, doi. 10.1007/s10637-019-00743-1
- By:
- Publication type:
- Article
GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1135, doi. 10.1007/s10637-019-00741-3
- By:
- Publication type:
- Article
Synergistic effect and reduced toxicity by intratumoral injection of cytarabine-loaded hyaluronic acid hydrogel conjugates combined with radiotherapy on lung cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1146, doi. 10.1007/s10637-019-00740-4
- By:
- Publication type:
- Article
Delineation of proapoptotic signaling of anthracene-shelled M<sub>2</sub>L<sub>4</sub> metallacapsules and their synergistic activity with curcumin in cisplatin-sensitive and resistant tumor cell lines.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1117, doi. 10.1007/s10637-019-00738-y
- By:
- Publication type:
- Article
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1198, doi. 10.1007/s10637-019-00736-0
- By:
- Publication type:
- Article
Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutations.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1207, doi. 10.1007/s10637-019-00732-4
- By:
- Publication type:
- Article
A phthalimidoalkanamide derived novel DNMT inhibitor enhanced radiosensitivity of A549 cells by inhibition of homologous recombination of DNA damage.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1158, doi. 10.1007/s10637-019-00730-6
- By:
- Publication type:
- Article
LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1127, doi. 10.1007/s10637-018-00721-z
- By:
- Publication type:
- Article
Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1231, doi. 10.1007/s10637-018-00716-w
- By:
- Publication type:
- Article